malondialdehyde has been researched along with Ovarian Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, H; Li, D; Zhang, M | 1 |
| Eissa, LA; El-Gayar, AM; Hemida, R; Nowara, A; Ramadan, A | 1 |
| Kayali, HA; Tavsan, Z | 1 |
| Matejcková, J; Rokyta, R; Samcová, E; Samec, M; Tůma, P | 1 |
| Bublevič, J; Didžiapetrienė, J; Kazbarienė, B; Smailytė, G; Stukas, R | 1 |
| Abakumova, TV; Antoneeva, II; Dolgova, DR; Fomina, AV; Gening, SO; Gening, TP; Pirmamedova, SS; Vasil'eva, EV | 1 |
| Abakumova, TV; Antoneeva, II; Dolgova, DR; Fomina, AV; Gening, SO; Gening, TP; Mikheenko, AA; Pirmamedova, SS | 1 |
| Davydova, TV; Gorozhanskaia, EG; Kormosh, NG; Laktionov, KP; Zubrikhina, GN | 1 |
| Sieja, K; Talerczyk, M | 1 |
| Lohn, JW; Seifalian, AM; Toffa, SE; Winslet, MC; Yang, W | 1 |
| Davydova, TV; Gorozhanskaia, EG; Kormosh, NG; Zubrikhina, GN | 1 |
| Sieja, K | 1 |
| Gogacz, M; Kotarski, J; Kozioł-Montewka, M; Polak, G; Rola, R | 1 |
2 trial(s) available for malondialdehyde and Ovarian Neoplasms
| Article | Year |
|---|---|
Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Cisplatin; Cyclophosphamide; Dietary Supplements; Erythrocytes; Female; Glutathione Peroxidase; Hair; Humans; Malondialdehyde; Middle Aged; Ovarian Neoplasms; Oxidative Stress; Selenium | 2004 |
Selenium (Se) deficiency in women with ovarian cancer undergoing chemotherapy and the influence of supplementation with this micro-element on biochemical parameters.
Topics: Adult; Aged; Antineoplastic Agents; Erythrocytes; Female; Glutathione Peroxidase; Hair; Humans; Malondialdehyde; Middle Aged; Ovarian Neoplasms; Selenium | 1998 |
11 other study(ies) available for malondialdehyde and Ovarian Neoplasms
| Article | Year |
|---|---|
Significance of glutathione peroxidase 4 and intracellular iron level in ovarian cancer cells-"utilization" of ferroptosis mechanism.
Topics: Animals; Apoptosis; Cell Line; Cell Proliferation; Deferoxamine; Female; Ferric Compounds; Ferroptosis; Humans; Interleukin-6; Iron; Malondialdehyde; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Phospholipid Hydroperoxide Glutathione Peroxidase; Quaternary Ammonium Compounds; Tumor Necrosis Factor-alpha | 2021 |
Role of oxidative stress in epithelial ovarian cancer in Egyptian patients.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Carcinoma, Ovarian Epithelial; Case-Control Studies; Cross-Sectional Studies; Egypt; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Oxidative Stress; Superoxide Dismutase; Young Adult | 2017 |
Flavonoids showed anticancer effects on the ovarian cancer cells: Involvement of reactive oxygen species, apoptosis, cell cycle and invasion.
Topics: Antineoplastic Agents; Antioxidants; Apigenin; Apoptosis; Cell Cycle; Cell Line, Tumor; Female; Flavonoids; Free Radical Scavengers; Humans; Inhibitory Concentration 50; Lipid Peroxidation; Luteolin; Malondialdehyde; Neoplasm Invasiveness; Ovarian Neoplasms; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Structure-Activity Relationship | 2019 |
The effect of vitamin E on plasmatic malondialdehyde levels during surgical removal of ovarian and endometrial carcinomas.
Topics: Adult; Aged; Antioxidants; Chromatography, High Pressure Liquid; Endometrial Neoplasms; Female; Humans; Malondialdehyde; Middle Aged; Ovarian Neoplasms; Vitamin E | 2013 |
Significance of blood serum catalase activity and malondialdehyde level for survival prognosis of ovarian cancer patients.
Topics: Adult; Aged; Biomarkers, Tumor; Catalase; Female; Humans; Kaplan-Meier Estimate; Malondialdehyde; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Oxidative Stress; Prognosis | 2014 |
[Redox-dependent processes in blood plasma, neutrophils and erythrocytes of patients with ovary cancer after polychemotherapy by CAP scheme].
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Catalase; Cisplatin; Cyclophosphamide; Doxorubicin; Erythrocytes; Female; Glutathione Transferase; Humans; Leukocyte Count; Lipid Peroxidation; Malondialdehyde; Neoplasm Staging; Neutrophils; Ovarian Neoplasms; Oxidative Stress; Peroxidase; Schiff Bases; Superoxide Dismutase | 2014 |
Effects of CAP-regimen Chemotherapy on Blood Redox Status in Patients with Ovarian Cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Catalase; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Glutathione Transferase; Humans; Malondialdehyde; Middle Aged; Ovarian Neoplasms; Oxidation-Reduction; Superoxide Dismutase | 2015 |
[Antioxidant system of platelets in patients with ovary cancer].
Topics: Adult; Antioxidants; Blood Platelets; Catalase; Female; Glutathione; Humans; Malondialdehyde; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Platelet Aggregation; Superoxide Dismutase | 2003 |
Malignant ascites increases the antioxidant ability of human ovarian (SKOV-3) and gastric adenocarcinoma (KATO-III) cells.
Topics: Adenocarcinoma; Antioxidants; Ascites; Blotting, Northern; Buthionine Sulfoximine; Cell Adhesion; Cell Line, Tumor; Cell Survival; Female; Gene Expression; Glutathione; Humans; Hyaluronan Receptors; Lipid Peroxidation; Malondialdehyde; Ovarian Neoplasms; Oxidative Stress; Stomach Neoplasms | 2005 |
[The oxidative stress in platelets of patients with ovary cancer as observed at chemotherapy].
Topics: Antineoplastic Agents; Blood Platelets; Female; Humans; Malondialdehyde; Ovarian Neoplasms; Oxidation-Reduction; Oxidative Stress; Oxidoreductases; Platelet Aggregation; Platelet Count | 2004 |
[Malonyldialdehyde and total antioxidant status in the peritoneal fluid of infertile women].
Topics: Adult; Antioxidants; Ascitic Fluid; Endometriosis; Female; Humans; Infertility, Female; Laparotomy; Lipid Peroxidation; Malondialdehyde; Ovarian Neoplasms | 1999 |